| The Pharmaceutical Journal |
| Striking-off follows dispensing
errors A pharmacist whose dispensing errors included supplying
dexamphetamine when dexamethasone was ordered and labelling oral tablets
to be inserted into the rectum has been ordered to be removed from the
register by the Statutory Committee [more] |
Striking-off follows dispensing errorsA pharmacist whose dispensing errors included supplying dexamphetamine when dexamethasone was ordered and labelling oral tablets to be inserted into the rectum has been ordered to be removed from the register by the Statutory Committee. At its hearing on 16 January, the committee inquired into the case of Errol G. D. Ganpatsingh, of 23 Harrington Road, Brighton, East Sussex. Mr Ganpatsingh is the proprietor of two pharmacies in Brighton, at 209 Preston Road and 88–90 Beaconsfield Road. Information had been received from the Council of the Royal Pharmaceutical Society alleging that Mr Ganpatsingh had made a number of dispensing errors while pharmacist in charge at the premises at 88–90 Beaconsfield Road. The alleged errors included the supply on 23 January 2001 of 28 dothiepin capsules 25mg and 28 dothiepin 75mg tablets when 100 dothiepin 25mg capsules had been prescribed, and failing to counsel the patient about the change of dose this necessitated. He had endorsed the prescription "OP Prothiaden", although generic dothiepin had been supplied. It was also alleged that on 29 January 2001 Mr Ganpatsingh had dispensed dexamphetamine tablets on a prescription ordering dexamethasone and, when the error had come to light, had retrieved the wrongly dispensed dexamphetamine tablets and had returned them into stock. Further, Mr Ganpatsingh was stated to have supplied, on 5 March 2001, Colofac tablets that were incorrectly labelled. Following those errors, it was alleged that Mr Ganpatsingh had failed to review procedures for dispensing and checking medicines at his pharmacy as he had been advised to do by the Society's inspectors. Geoff Hudson, of Penningtons (solicitors), appeared in order to present the facts of the case to the committee. Oliver Britton, of Turner & Debenhams (solicitors) represented Mr Ganpatsingh, who was present at the hearing. The committee heard that one of the Society's inspectors had visited Mr Ganpatsingh on 23 October 2000 in connection with two dispensing errors that had taken place in August of that year. The first involved the supply of candesartan 8mg tablets when the prescription had called for ondansetron 8mg; the second error was that diazepam 2mg had been supplied and labelled digoxin 62.5mcg, when the latter had been prescribed. Following the visit, a letter had been sent to Mr Ganpatsingh on 19 January 2001, reinforcing verbal advice given on the October visit that he should review his dispensing and checking procedures, and pointing out that staffing levels in the pharmacy did not seem sufficient for the volume of work being done. The letter required that he should reply within 21 days, confirming that he had followed the advice given. When no reply was received, a further letter was sent. Mr Ganpatsingh claimed he had received neither letter. Meanwhile, the Society received further complaints about dispensing errors. On 23 January 2001, on a prescription for 100 dothiepin 25mg capsules, 28 dothiepin 75mg tablets in one container and 28 capsules of 25mg in another container were supplied. Instead of the prescriber's directions that two capsules should be taken at night for five days, then three capsules at night, he had labelled both containers "take one at night". The patient's prescription records stated that 120 capsules of 25mg had been supplied. The patient had taken one of each strength for four nights and experienced extreme drowsiness. She consulted her doctor and the complaint resulted. The complaint about the dexamphetamine tablets arose after a patient who happened to be a nurse visited the pharmacy to collect the balance owing on a prescription for dexamethasone. She saw the container being taken from the dispensary shelves, not from the Controlled Drugs cabinet. After returning home, she found that she had been given dexamphetamine tablets. She had telephoned Mr Ganpatsingh, who went to her house and exchanged the dexamphetamine for the correct tablets. During the course of an interview with the Society's inspector, Mr Ganpatsingh had admitted that he had returned the dexamphetamine tablets to the Controlled Drugs cupboard for redispensing. The incident relating to the Colofac tablets took place on 5 March 2001. The medication was properly dispensed but instead of being labelled "one to be taken three time a day before food", as prescribed, the container was labelled "Place one high in the rectum (remove wrapper) before food". The patient telephoned the pharmacy to query this; Mr Ganpatsingh apologised and delivered a new label. Serious consequences Giving the committee's decision, the chairman (Lord Fraser of Carmyllie, QC), said that little was disputed about the matters complained of. Dealing first with the supply of dothiepin, he said that there had been serious consequences for the patient. Having had no opportunity to understand what she should have been taking, she took something like twice the amount her doctor had advised. This had caused her to become exceptionally drowsy and had also meant that the course of medication prescribed could not be followed in the appropriate manner. Coupled with that was Mr Ganpatsingh's failure to counsel the patient about the changes to the dosage necessitated by his having dispensed 75mg tablets and the endorsing of the prescription "OP Prothiaden" despite the fact that he had dispensed at least some of the generic equivalent. The supply of dexamphetamine against a prescription calling for dexamethasone was also a serious matter. They were very different medications. It was particularly careless to give a patient a Controlled Drug against a prescription that did not call for it. Furthermore, he should not have returned to stock the dexamphetamine tablets that had been wrongly dispensed. The committee felt the incorrect labelling of the Colofac tablets was extraordinary. While no harm had been caused to the patient, because he had noticed that the instructions on the label were incorrect, it was a serious dispensing error. Turning to Mr Ganpatsingh's failure to review his dispensing procedures in accordance with the advice given by the Society, The chairman said that this did not loom as large in the committee's consideration as might have been thought. That was because in any pharmacy not only should there be procedures for dispensing and checking but they should be rigorously observed. That was an integral part of the profession of being a pharmacist. Any experienced pharmacist, such as Mr Ganpatsingh, should have been aware of that, whether or not he had received advice or letters from the Pharmaceutical Society. Mr Ganpatsingh should have laid down proper procedures for dispensing and checking and, as the pharmacist owner, should have been the first person to ensure that those procedures were wholly carried through. However, it appeared that he had not even followed the procedures he did have in place. Mr Ganpatsingh had been personally responsible for the serious errors that had been established; they amounted to misconduct such as to make him unfit to be on the register. The committee was informed that Mr Ganpatsingh had been reprimanded in 1994 (over a different matter). It had been directed on that occasion that that decision should be brought before the committee if he were to appear before them again. Mr Ganpatsingh's name was ordered to be struck from the register. He had three months in which to appeal against the decision The chairman added that members of the committee, who had been told that Mr Ganpatsingh was awaiting an operation for cataracts, had expressed their concern about his eyesight. If Mr Ganpatsingh wished at some time in the future to apply for restoration the committee would, among other things, have to be satisfied that his eyesight had improved sufficiently to allow him to resume his profession. |
Practising as a pharmacist while not on the register leads to striking offThe name of a pharmacist who had continued to practise after being removed from the register for non-payment of fees, and who had not provided an address at which he could be contacted after his restoration, has been struck off. At its meeting on 14 January, the committee inquired into the case of Philip F. Sloane, whose registered address is 1 Catton Grove, Norwich. A complaint had been received from the Council of the Royal Pharmaceutical Society alleging that after his removal from the register for non-payment of fees on 2 June 1999, Mr Sloane had worked as a pharmacist for 74 days between that date and 29 October 1999. Mr Sloane had also failed to make adequate arrangements to ensure that correspondence sent to his registered address by the Society was properly dealt with. Geoff Hudson, of Penningtons (solicitors), attended in order to place the facts of the case to the committee. Mr Sloane was not present and was not represented. The committee heard that on 8 January 2000, after his removal from the register, Mr Sloane had contacted the Society. He was advised that before his name could be restored he had to provide an address at which he could be contacted. On 1 March 2000, Mr Sloane had sent in the necessary fees, listing his address as 1 Catton Grove, Norwich, and his name had been restored to the register. The address was that of a guest house. Subsequently, the fact came to light that Mr Sloane had worked as a pharmacist while not on the register. Attempts to communicate with him, including recorded delivery letters sent to that address on matters relating to his alleged misconduct in practising after the removal of his name, and advising him of the forthcoming hearing by the committee, had failed. The chairman (Lord Fraser of Carmyllie, QC), giving the committee's decision, said that Mr Sloane had not appeared at the hearing and there had been no indication that he would want to seek an adjournment. All steps required to give notice of the proceedings had been properly taken and it would not be in the public interest to allow the case to drag on. It had been established that Mr Sloane had worked for 74 days after his removal from the register. That amounted to misconduct such as to render him unfit to have his name on the register. His failure to make arrangements to ensure that correspondence sent to him by the Society would be received was also misconduct that would make him unfit to be on the register. It was essential, said the chairman, that the Royal Pharmaceutical Society should have an address at which it can communicate with the pharmacist in question. The committee ordered that Mr Sloane's name should be struck off. Notice of his removal from the register was published in The Pharmaceutical Journal of 26 January (p120). |
Home | Journals | News | Notice-board | Search | Jobs Classifieds | Site
Map | Contact us
©The Pharmaceutical Journal